Ebru Bodur
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Pharmacology 18
- Cholinesterase and Neurodegenerative Diseases 17
-
- Computational Drug Discovery Methods 16
- Co-authors
- Müge Yemişçi (4 shared papers)Yasemin Özdemir (3 shared papers)Turgay Dalkara (4 shared papers)Yılmaz Çapan (2 shared papers)Secil Caban-Toktas (2 shared papers)Ömer Faruk Türkoğlu (8 shared papers)Hülya Karataş (2 shared papers)Hakan Eroğlu (6 shared papers)
- Journals
- Chemico-Biological Interactions (5 papers)The Protein Journal (5 papers)Biochimie (3 papers)Journal of Neurochemistry (2 papers)Molecular Biology Reports (1 paper)
- Partner nations
- TürkiyeUnited StatesItaly
In The Last Decade
Ebru Bodur
38 papers receiving 639 citations
Peers
Comparison fields: 5 of 85
- Pharmaceutical Science 63
- Biomaterials 135
- Pharmacology 141
- Neurology 58
- Developmental Neuroscience 23
Countries citing papers authored by Ebru Bodur
This map shows the geographic impact of Ebru Bodur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebru Bodur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebru Bodur more than expected).
Fields of papers citing papers by Ebru Bodur
This network shows the impact of papers produced by Ebru Bodur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebru Bodur. The network helps show where Ebru Bodur may publish in the future.
Co-authors
The 25 scholars most cited alongside Ebru Bodur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 167 | |
| 2 | 2011 | 43 | |
| 3 | 2012 | 33 | |
| 4 | 2008 | 27 | |
| 5 | 2012 | 26 | |
| 6 | 2023 | 25 | |
| 7 | 2020 | 24 | |
| 8 | 2007 | 19 | |
| 9 | 2001 | 19 | |
| 10 | 2005 | 18 | |
| 11 | 2010 | 18 | |
| 12 | 2022 | 17 | |
| 13 | 2022 | 17 | |
| 14 | 2016 | 16 | |
| 15 | 2003 | 16 | |
| 16 | 2010 | 15 | |
| 17 | 2023 | 15 | |
| 18 | 2012 | 15 | |
| 19 | 2010 | 14 | |
| 20 | 2016 | 14 |
About Ebru Bodur
Ebru Bodur is a scholar working on Pharmacology, Computational Theory and Mathematics, Plant Science, Complementary and alternative medicine and Biochemistry, having authored 40 papers that have together received 655 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (17 papers), Computational Drug Discovery Methods (16 papers), Pesticide Exposure and Toxicity (9 papers), Medicinal Plants and Neuroprotection (4 papers), Biochemical Acid Research Studies (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers) and Free Radicals and Antioxidants (2 papers). The work is most often cited by research in Pharmaceutical Science (63 citations), Biomaterials (135 citations), Pharmacology (141 citations), Neurology (58 citations) and Developmental Neuroscience (23 citations). Ebru Bodur has collaborated with scholars based in Türkiye, United States and Italy. Frequent co-authors include Müge Yemişçi, Yasemin Özdemir, Turgay Dalkara, Yılmaz Çapan, Secil Caban-Toktas, Ömer Faruk Türkoğlu, Hülya Karataş, Hakan Eroğlu, Mustafa Fevzi Sargon and Levent Öner. Their work appears in journals such as Chemico-Biological Interactions, The Protein Journal, Biochimie, Journal of Neurochemistry and Molecular Biology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.